TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
DYN

Dyne Therapeutics Inc

Healthcare · Biotechnology

16.00$ +3.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 994 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DYN
Line item Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
12,157 11,539 11,708 13,162 13,024 13,053 13,080 12,759 12,007 11,771 – – – 16 – 147 381 353 492 467 467 426 388 340 300 306 289 251 205 165 522 826 769 691 721 729 867 1,187 1,080 994
2,267 1,945 2,281 2,441 2,639 2,987 1,691 1,590 1,704 1,524 8.1 – – 15 15 145 380 349 487 461 425 382 344 298 258 266 249 213 168 129 488 792 736 659 690 698 806 1,127 1,021 938
934 505 821 1,142 1,458 1,776 467 447 613 365 -8.1 – – 15 -15 145 380 301 311 258 229 201 148 136 145 172 181 168 130 122 272 608 532 435 472 485 574 893 753 676
1,003 605 998 1,206 1,531 1,906 596 530 663 397 8.1 – – 15 15 145 380 345 483 436 408 377 323 292 248 256 238 208 158 123 454 779 724 642 677 684 792 1,111 972 898
436 402 339 392 374 386 394 441 478 513 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
531 597 579 520 447 445 513 477 429 445 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – 1.5 1.5 1.4 1.9 2.3 3.0 40 41 – 40 39 38 – 36 – – – – – – – – – – – –
818 797 797 799 799 799 799 799 772 772 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
120 102 81 70 54 38 31 23 24 25 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
8,975 8,618 8,799 10,694 10,813 11,011 10,654 10,636 10,018 9,870 – – – 2.4 – 14 15 11 13 15 53 57 51 53 50 54 47 45 53 74 44 51 63 61 52 158 175 215 215 292
1,010 812 863 749 911 916 904 903 867 1,049 – – – 2.4 4.1 4.1 4.7 11 13 15 23 29 23 26 23 28 22 20 30 51 22 30 43 42 34 41 60 51 51 78
71 83 108 141 167 201 117 106 99 105 – – – – – – – – 0.6 0.4 4.6 3.9 4.7 5.5 4.6 4.6 4.6 4.7 4.7 4.7 4.8 4.8 4.8 4.9 5.1 5.0 5.0 5.0 5.0 5.4
315 292 243 286 263 332 287 370 288 367 – – – 1.3 2.2 2.2 1.5 3.4 5.8 5.6 7.1 4.0 5.2 7.0 0.9 5.3 8.8 2.7 3.6 23 7.2 1.9 6.2 6.6 7.0 14 12 8.1 11 12
– – – – – – – – – – – – – – – 9.9 9.9 – – – – – – – – – – – – – – – – – – 99 99 149 149 199
3,182 2,921 2,909 2,468 2,211 2,042 2,426 2,123 1,989 1,901 4.2 – – 14 14 132 367 342 478 453 414 368 336 287 250 252 242 207 152 91 478 775 706 630 669 571 692 972 865 702
-552 -686 -696 -1,497 -1,746 -1,927 -1,330 -1,626 -1,758 -1,851 – – – -20 -37 -37 -51 -79 -104 -134 -177 -228 -264 -316 -358 -397 -441 -506 -566 -633 -698 -763 -860 -950 -1,065 -1,176 -1,284 -1,396 -1,517 -1,696
140 126 118 118 126 129 162 162 162 162 2.4 2.4 13 13 13 42 45 45 49 51 51 52 52 52 52 52 56 60 61 61 81 93 101 102 110 114 142 128 165 165

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?